EchoGo® Heart Failure vs FibriCheck
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, EchoGo® Heart Failure, is designed for clinical decision support, utilizing AI to diagnose HFpEF from echocardiograms within a healthcare setting. In contrast, Tool B, FibriCheck, is a patient-facing mobile application that enables remote heart rhythm monitoring for arrhythmia detection using a smartphone. While both are cardiology AI tools, their distinct focus on diagnostic imaging analysis versus patient-driven remote monitoring positions them as complementary rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure (Tool A) is an AI platform that analyzes routine echocardiograms to detect Heart Failure with preserved Ejection Fraction (HFpEF), providing insights to support clinical decisions. FibriCheck (Tool B) is a medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias, such as Atrial Fibrillation, using their smartphone.
EchoGou00ae Heart Failure (Tool A) offers seamless integration with existing IT stacks and workflows, delivering automated structured reports via DICOM to PACS within 20 minutes. FibriCheck (Tool B) provides a patient-facing mobile application for measurements and a healthcare professional portal/dashboard for patient monitoring, with API-based integration into existing EHRs and RPM platforms.
EchoGou00ae Heart Failure (Tool A) is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers. FibriCheck (Tool B) is available via subscription for end-users or through licensing agreements for healthcare providers, with specific patient prescription pricing options.
EchoGou00ae Heart Failure (Tool A) analyzes routine echocardiogram video clips, specifically an apical 4-chamber view, using its AI platform to detect HFpEF. FibriCheck (Tool B) uses smartphone camera-based photoplethysmography (PPG) technology to measure heart rhythm, which is then analyzed by an AI-powered algorithm for arrhythmia detection.
Both EchoGou00ae Heart Failure (Tool A) and FibriCheck (Tool B) are FDA-cleared. FibriCheck is also medically certified and states HIPAA compliance for US operations.
EchoGou00ae Heart Failure (Tool A) is primarily used by interpreting clinicians as a diagnostic aid within clinical settings to analyze echocardiograms. FibriCheck (Tool B) is a patient-facing mobile application for self-testing and monitoring, with a professional portal for healthcare providers to review patient data and manage alerts.
EchoGou00ae Heart Failure (Tool A) is clinically validated with 90% sensitivity and 86% specificity for HFpEF detection. FibriCheck (Tool B) reports an accuracy of 98.3% sensitivity and 99.9% specificity for AF detection in independent external validation studies.